 Karuna Therapeutics NASDAQ:KRTX Equities researchers at Oppenheimer lifted their FY2024 EPS estimates for Karuna Therapeutics in a report released on Wednesday, June 24th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings of 3.84 per share for the year, up from their prior estimate of 4.11. Oppenheimer currently has a Outperform ... 